tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SVRA Stock Latest News

Savara announces encore presentations from Molgramostim Phase 3 IMPALA-2 trial
The FlySavara announces encore presentations from Molgramostim Phase 3 IMPALA-2 trial
12d ago
SVRA
Savara’s Strategic Advancements and Market Potential of Molbreevi: A Transformative Approach to aPAP Treatment
PremiumRatings
Savara’s Strategic Advancements and Market Potential of Molbreevi: A Transformative Approach to aPAP Treatment
22d ago
SVRA
Savara’s Strategic Positioning and Market Potential for Molbreevi in aPAP Treatment
PremiumRatings
Savara’s Strategic Positioning and Market Potential for Molbreevi in aPAP Treatment
23d ago
SVRA
Savara reports Q4 EPS (13c), consensus (11c)
PremiumThe Fly
Savara reports Q4 EPS (13c), consensus (11c)
23d ago
SVRA
Savara Secures $200 Million Loan Agreement with Hercules
PremiumCompany Announcements
Savara Secures $200 Million Loan Agreement with Hercules
24d ago
8K
SVRA
Savara completes BLA submission to FDA for Molbreevi
PremiumThe FlySavara completes BLA submission to FDA for Molbreevi
24d ago
SVRA
Savara’s Innovative Testing and BLA Submission Drive Buy Rating Amid Market Growth Potential
Premium
Ratings
Savara’s Innovative Testing and BLA Submission Drive Buy Rating Amid Market Growth Potential
1M ago
SVRA
Savara Sets 2025 Executive Bonus Targets
Premium
Company Announcements
Savara Sets 2025 Executive Bonus Targets
3M ago
8K
SVRA
Savara Highlights MOLBREEVI’s Potential in Rare Disease Market
PremiumCompany Announcements
Savara Highlights MOLBREEVI’s Potential in Rare Disease Market
3M ago
8K
SVRA
Savara initiated with an Overweight at Wells Fargo
PremiumThe Fly
Savara initiated with an Overweight at Wells Fargo
4M ago
SVRA
Savara initiates rolling submission of BLA to FDA for MOLBREEVI
PremiumThe Fly
Savara initiates rolling submission of BLA to FDA for MOLBREEVI
4M ago
SVRA
Savara downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Savara downgraded to In Line from Outperform at Evercore ISI
5M ago
SVRA
Savara price target lowered to $6 from $10 at H.C. Wainwright
PremiumThe FlySavara price target lowered to $6 from $10 at H.C. Wainwright
5M ago
SVRA
Savara management to meet virtually with Piper Sandler
Premium
The Fly
Savara management to meet virtually with Piper Sandler
7M ago
SVRA
3 Best Stocks to Buy Now, 10/1/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 10/1/2024, According to Top Analysts 
7M ago
CCL
SVRA
Savara announces EAP for molgramostim for patients with aPAP
PremiumThe Fly
Savara announces EAP for molgramostim for patients with aPAP
7M ago
SVRA
Savara appoints Braden Parker as chief commercial officer
PremiumThe Fly
Savara appoints Braden Parker as chief commercial officer
7M ago
SVRA
Savara announces new data from Pivotal Phase 3 IMPALA-2 trial
PremiumThe Fly
Savara announces new data from Pivotal Phase 3 IMPALA-2 trial
7M ago
SVRA
Savara price target lowered to $9 from $10 at JMP Securities
PremiumThe Fly
Savara price target lowered to $9 from $10 at JMP Securities
8M ago
SVRA
Savara reports Q2 EPS (12c), consensus (11c)
PremiumThe FlySavara reports Q2 EPS (12c), consensus (11c)
8M ago
SVRA
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
10M ago
DJT
AISP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
10M ago
WVE
CASI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >